Cerebral Small Vessels Disease Completed Phase 2 Trials for Tadalafil (DB00820)

Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease

IndicationStatusPhase
DBCOND0072196 (Cerebral Small Vessels Disease)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02801032Effect of Tadalafil on Cerebral Large Arteries in StrokeTreatment